FOR IMMEDIATE RELEASE

Burton, MI, USA – January 9, 2026 – Javelin Sciences, a CLIA-certified biotechnology leader, today announced a significant advancement in peptide research with the launch of the world's first topical formulation of the KLOW80 peptide blend. This innovative product, now available for qualified researchers, features a synergistic blend of four regenerative peptides, with GHK-Cu (copper tripeptide-1, commonly known as blue copper peptide) as its primary component.

Copper peptides, recognized for their ability to stimulate collagen production, improve skin elasticity, and accelerate wound healing, are among the most researched anti-aging ingredients. Traditionally, research on such peptide complexes relied on injectable methods. Javelin Sciences' new topical formula is designed to enable non-invasive, localized studies on skin repair, inflammation modulation, and wound healing, potentially accelerating applied research in dermatology and regenerative medicine.

Concurrently, innovation continues in material science. A Chinese university recently secured a patent for a multifunctional hydrogel integrated with blue copper peptide, showcasing its potential in advanced biomedical applications like antibacterial and antioxidant wound dressings. These developments underscore a growing trend: the transition of copper peptide from a prized cosmetic ingredient into a versatile molecule for serious clinical and biotechnological research.

【 Go Back 】 | 【 Print 】